AP-401

N/A

Report date: 2024/04/24 14:56:17

Base Information

Drug NameAP-401

Drug Alias NameAP-401

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy

Mechanisms of ActionPoliovirus receptor modulators5'-nucleotidase modulators

TargetsPoliovirus receptor5'-nucleotidase

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAlphageneron Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesAlphageneron Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A